Libivirumab
Libivirumab is a human monoclonal antibody directed against the hepatitis B virus.[1][2]
References
- ^ WHO Drug Information
- ^ Shouval, D; et al. (2006). "Anti-Viral Effects, Pharmacokinetics and Safety of Two Human Monoclonal Anti-Hbs (Libivirumab/Exbivirumab) Versus Hepatitis B Immune Globulin (Hbig) in Hepatits B Virus (Hbv) in Liver Transplant (Lt) Recipients". Hepatology 44 (4): 188A–700A. doi:10.1002/hep.21395. PMID 17001593.
|
|
Fungal ("-fung-") |
|
|
Viral ("-vi(r)-") |
|
|
Bacterial ("-ba(c)-") |
Human ("-bacu-")
|
|
|
Mouse ("-baco-")
|
|
|
|
|
|
Humanized ("-bazu-")
|
|
|
|
Toxin ("-tox(a)-") |
|
|
|
|